NTLA
Intellia Therapeutics Inc

12,798
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 10,
Pre-Market

Estimated EPS

-$1.01

Estimated Rev

$13.8M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$1.01
--
--
N/A
Q2 '25
-$1.02
-$0.98
3.70%
BEAT
Q1 '25
-$1.28
-$1.10
14.00%
BEAT
Q4 '24
-$1.34
-$1.27
5.44%
BEAT
Q3 '24
-$1.39
-$1.34
3.61%
BEAT

Latest NTLA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.